Jill Wechsler - Profile and Journalist Details

Beats

Content

Total articles 663

• FDA, Industry Face Challenges in the Year Ahead

  By Jill Wechsler Verified| Pharmaceutical Executive Verified In the 30 years that I have been writing about FDA policy and biopharmaceutical research and drug manufacturing, I have not encountered a time as uncertain as the present. The political battles over medicines for abortion, vaccine safety, and shortages in vital treatments threaten to undermine long-held confidence and support for the nation's regulatory system for food, drugs, and medical products.

  By Jill Wechsler Verified · Pharmaceutical Executive

  Dec. 11, 2023

• FDA Inspections Face Continued Overhaul and Changes

  By Jill Wechsler Verified| Applied Clinical Trials Verified Published on: Applied Clinical Trials, Applied Clinical Trials-10-01-2023, Volume 32, Issue 10Agency will be reorganizing field force and compliance functions. As part of agency initiatives to strengthen its oversight of human food and food products, FDA is revising inspection and compliance programs for all regulated products, at home and abroad.

  By Jill Wechsler Verified · Applied Clinical Trials

  Oct. 13, 2023

• FDA, Industry Face Challenges in the Year Ahead

  By Jill Wechsler Verified| Pharmaceutical Executive Verified In the 30 years that I have been writing about FDA policy and biopharmaceutical research and drug manufacturing, I have not encountered a time as uncertain as the present. The political battles over medicines for abortion, vaccine safety, and shortages in vital treatments threaten to undermine long-held confidence and support for the nation's regulatory system for food, drugs, and medical products.

  By Jill Wechsler Verified · Pharmaceutical Executive

  Dec. 11, 2023

As seen in

Company Info

Pharmaceutical Executive

NeurologyLive is a multimedia platform focused on delivering the latest news and insights in the field of neurology. It serves as a valuable resource for healthcare professionals, particularly those treating neurological diseases. The platform offers a combination of print and digital media, ensuring that busy clinicians stay informed about significant developments in neurology. The services provided by NeurologyLive include breaking news on drug approvals, clinical trials, and emerging trends in neurological care. It features expert interviews with leading neurologists, offering insights into the latest research and clinical practices. The use of multimedia content makes the information accessible and engaging for its audience. NeurologyLive targets healthcare professionals such as neurologists, clinicians, and researchers. It has established strategic partnerships with organizations like the Consortium of Multiple Sclerosis Centers, enhancing its credibility and reach within the neurology community. Its comprehensive coverage and expert engagement position NeurologyLive as a trusted source for the latest developments in the field.